“showed a trend”

A subset analysis of stage 3 patients showed a trend associating poor survival with serum RASSF1A methylation ( P =0.055), although the data were limited due to the small number of patients in the subgroup.

In our study, preoperative smoking showed a trend toward association with postoperative hypoxemia ( P = .055), although it did not reach conventional statistical significance.

In multivariable Cox analysis of non-RLO patients, restrictive ventilatory defects showed a trend toward worse outcomes (Hazard ratio [HR]: 2.56, 95% CI: 0.98–6.71; p = 0.055), while obstructive defects showed no association (HR: 0.88, p = 0.785).

Accordingly, in our analyses, intratumoural CD68 + TAMs did not associate with stage ( P =0.629) or recurrence rate ( P =0.619), whereas peritumoural CD68 + TAMs showed a trend towards lower cell densities in advancing stage ( P =0.055) and in the presence of recurrences ( P =0.080).

The FFA showed a trend effect of time ( F 1,93 = 3.78, β = −0.08, SE = 0.04, effect size = 0.35, p = 0.055), with less habituation in both groups at follow-up compared to baseline (no group by time interaction, p = 0.58).

Only the transglottic larynx showed a trend for change (p = 0.055).

There was no significant difference as regards gender, ethnicity, age and baseline immune-virological status between the two groups although females showed a trend towards a higher frequency of NVP-induced hepatotoxicity (75.0% vs 35.9%; p = 0.055).

Similar to PFS, histologic grade significantly impacted OS in univariate analysis (p=0.012) and showed a trend in multivariate analysis (p=0.055).

Quantification of L-2-hydroxyglutarate showed a trend (P = 0.055) to decrease in the OB of the Ndufs4 KO mouse ( Fig. 2 E), whereas α-ketoglutarate concentration was unchanged ( Fig. 2 F).

Elevated GLS1 protein expression in TNBCs ( n = 71) showed a trend toward correlation with worse overall survival (HR = 2.258, P = 0.055, log-rank test) ( Fig.

OS calculated from the beginning of immunotherapy showed a trend between patients with a CD3 + CD137 + PD1 + frequency < 1.85% and > 1.85% ( P = 0.055); however, this difference was not statistically significant ( Fig. 4E ).

A more proximal entry point showed a trend toward increased risk of SBRN injury ( p = 0.055), with a potential threshold at approximately 18 mm from the distal radial physis.

A linear mixed-effect model showed a trend for the group × time interaction towards significance (F(2, 39.82) = 3.13, p = 0.055; see Table 4 B).

Within this, endpoint voxel assessment of GABA+ data was possible in 5/11 simvastatin and 9/15 placebo and showed a trend towards between-group increase in the simvastatin group compared to placebo (mean 1.82 placebo vs. 2.39 simvastatin ( t (12) = − 2.12, p = .055, two-tailed uncorrected), although this was not present when adjusted for baseline values (ANCOVA p = 0.188, Mann-Whitney p = 0.66; Fig. 3 a).

After exclusion of this observation, the association no longer reached significance but rather showed a trend-level effect (Spearman r = 0.473, p = 0.055).

Patients treated with HFNO + awake-PP showed a trend for delay in intubation compared to HFNO alone [median 1 (interquartile range, IQR 1.0–2.5) vs 2 IQR 1.0–3.0] days ( p = 0.055), but awake-PP did not affect 28-day mortality [RR 1.04 (95% CI 0.40–2.72), p = 0.92].

For WC a significant increase was found in males (1.6 cm; p <0.001), while females showed a trend towards a significant increase (0.6 cm; p = 0.055) between year 4 and 5 (T4-T5).

with D-CATH-2 showed a trend towards a lower MLS (p = 0.055).

Secondary outcome measure Amongst patients who received information compared to those who did not, those who received information showed a trend in reporting the study experience as being better than expected rather worse or same as expected (p = 0.055).

However, cyclists scored higher on sleep‐related behaviors, including sports‐related factors ( p = 0.035, d = 0.54), habitual sleep efficiency ( p = 0.012, d = 0.76), and showed a trend toward better sleep quality ( p = 0.055, d = 0.51) and greater total sleep behavior scores (ASBQ‐Total, p = 0.004, d = 0.82). 3.3.

CFAB cognitive control showed a trend toward association with DTC verbal fluency tasks (B-1.569, p = 0.055) and was significantly associated with DTC arithmetic tasks (B=−1.599, p = 0.032).

Overall memory showed a trend for a main group effect, F (1,56) = 3.825, p = 0.055, but no effect of time, F (1,56) = 0.363, p = 0.549, and no interaction, F (1,56) = 1.008, p = 0.32.

Analysis of gender suggested that male participants showed a trend towards responding faster for targets at invalid rather than valid target locations [i.e., those not coinciding with a motion cue; F(1,62) = 3.8, p = 0.055], which is reminiscent of an inhibition effect often observed during nonsocial orienting 23 , 79 , and dovetails with Bayliss et al . 42 who also found no gender differences during nonsocial orienting.

At 20 weeks of age, wolves only showed a trend towards a significant difference in response latency (Wilcoxon matched-pairs signed ranks test: N = 9, T = 6, p = 0.055, Figure 5 ).

DACH1 positivity was associated with good survival in patients treated with tamoxifen (χ 2 = 8.30, p = 0.004) and in addition, also showed a trend in patients not receiving tamoxifen (χ 2 = 3.7, p = 0.055).